Clinical Grade Disinfectant Market

Clinical Grade Disinfectant Sales Surge amid Covid-19 Outbreak

It would be premature to determine the effect of Covid-19 on the demand for clinical grade disinfectant as the virus spread is uncertain. The global pandemic has put forth opportunities for the global clinical grade disinfectant market to grow prosperously.

Governments across the globe have advocated safety and wellbeing of their people and are enhancing medical facilities to treat patients with COVID-19. Sudden increase in expenditure and sourcing of hygiene products by medical facilities has led to a significant uptick in demand for clinical grade disinfectant.

The upsurge in the demand of clinical grade disinfectant from private clinics, hospitals and medical facility premises is projected to escalate sales of clinical grade disinfectant. With the ongoing pandemic, global clinical grade disinfectant market is expected to witness a year-on-year growth of around 23% in 2020 over 2019.

Proliferation of Isolation Facilities to Give an Uptick to Demand for Clinical Grade Disinfectants

There more than 112 thousand medical hospitals including government and private facilities across the globe. These institutions are likely to multiply their demand for clinical grade disinfectant. Moreover, countries such as China, India, United States and most of the European countries have turned their government facilities into medical emergency centers owing to impact of Covid-19.

Government’s stringent policies over sterilization and disinfection of medical facilities owing to Covid-19 pandemic is projected to boost sales of clinical grade disinfectant in the mid-term. Besides, even after the situation has been bought under control, the demand of hygiene products including clinical grade disinfectants is expected to scale up over threat of re-emergence of virus.

Europe to Dominate Global Demand for Clinical Grade Disinfectant

In the clinical-grade disinfectant market, Europe accounts for nearly one-third of the market share and is expected to show significant growth over the forecast period. This growth in demand for clinical-grade disinfectants in the region can be attributed to higher than average spending on cleaning and disinfection of healthcare facilities owing to the COVID-19 pandemic.

As of date, Europe has shown the highest cases for COVID-19 and the number is escalating. Demand for clinical-grade disinfectants in Europe is expected to grow 1.3X in 2020 over 2019.

Clinical Grade Disinfectant Market will Remain Consolidated, Despite Emergence of Domestic and Local Market Players

Clinical grade disinfectant market is consolidated with top players accounting for nearly 60% of the sales revenue. COVID-19 pandemic is expected to lead to the emergence of new domestic players in clinical grade disinfectant market. Existing players like Dow Chemical, BASF SE, Ecolab, Inc. and Lonza Group have been working to address the booming demand for clinical grade disinfectant.

Clinical Grade Disinfectant Market: Segmentation

Fact MR’s study has done the segmentation of the clinical grade disinfectant market on the basis of formulation, end-users, sales channel, and region

• By Formulation :

  • Quaternary Ammonium Compounds
  • Chlorine Compounds
  • Alcohols & Aldehydes
  • Phenolic Compounds
  • Other Product Types

• By End-User :

  • Hospitals
  • Clinics
  • Pathology Labs
  • Research Institutes
  • Other End Users

• By Sales Channel :

  • Direct Sales
  • Online Sales Channel
  • Specialty Stores
  • Other Sales Channel

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA